Rotavirus Vaccine, Live, Oral, Pentavalent

BIOLOGICAL9 trials

Conditions

DiphtheriaDiphtheria ImmunisationGastroenteritisHaemophilus Influenzae Type b ImmunisationHealthy Volunteers (Meningococcal Infection)Hepatitis B ImmunisationMeasles ImmunisationMumps Immunisation

Phase 1

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

CompletedNCT00953056

Merck Sharp & Dohme LLCRotavirus Gastroenteritis

Start: 2009-09-30End: 2010-03-31Updated: 2015-11-02

Phase 2

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

CompletedNCT04398706

Sanofi Pasteur, a Sanofi CompanyDiphtheria Immunisation, Haemophilus Influenzae Type b Immunisation, Hepatitis B Immunisation +8

Start: 2020-05-22End: 2023-08-10Updated: 2025-09-08

Phase 3

Consistency Lots Vaccine Study (V260-009)

CompletedNCT00092456

Merck Sharp & Dohme LLCRotavirus Infections

Start: 2003-05-31End: 2004-08-31Updated: 2015-10-05

Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)

CompletedNCT00130832

Merck Sharp & Dohme LLCGastroenteritis, Rotavirus Infections

Start: 2005-10-31End: 2006-07-31Updated: 2015-04-01

V260 Registration Study (V260-013)(COMPLETED)

CompletedNCT00166517

Merck Sharp & Dohme LLCRotavirus

Start: 2005-08-31End: 2006-07-31Updated: 2015-04-01

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

CompletedNCT00258154

Merck Sharp & Dohme LLCRotavirus Disease

Start: 2006-02-28End: 2006-11-30Updated: 2015-10-06

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

CompletedNCT00496054

Merck Sharp & Dohme LLCGastroenteritis, Rotavirus

Start: 2008-05-31End: 2008-10-31Updated: 2017-04-13

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

WithdrawnNCT01003431

Merck Sharp & Dohme LLCDiphtheria, Pertussis, Rotavirus Gastroenteritis +1

Start: 2009-12-31End: 2010-09-30Updated: 2015-10-09

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

CompletedNCT03691610

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)

Start: 2018-10-04End: 2023-10-20Updated: 2024-06-25

Related Papers

Meningococcal quadrivalent ACYW-TT conjugated vaccine at 6–23 months: phase III study (US/Puerto Rico)

Pediatric Research2026-03-06

P-662. Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of age in the United States

Open Forum Infectious Diseases2025-01-29

Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants.

2013-01-0112 citations